TreeWAS – Variant ID: rs78745845

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Showing all nodes without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
C78.7 Secondary malignant neoplasm of liver	0.119	0.881	0.000
C78 Secondary malignant neoplasm of respiratory and digestive organs	0.115	0.885	0.000
C78.2 Secondary malignant neoplasm of pleura	0.107	0.893	0.000
C78.6 Secondary malignant neoplasm of retroperitoneum and peritoneum	0.104	0.896	0.000
C78.0 Secondary malignant neoplasm of lung	0.088	0.912	0.000
C78.8 Secondary malignant neoplasm of other and unspecified digestive organs	0.087	0.913	0.000
C78.4 Secondary malignant neoplasm of small intestine	0.082	0.918	0.000
C78.3 Secondary malignant neoplasm of other and unspecified respiratory organs	0.082	0.918	0.000
C78.1 Secondary malignant neoplasm of mediastinum	0.082	0.918	0.000
C78.5 Secondary malignant neoplasm of large intestine and rectum	0.077	0.923	0.000
C76-C80 Malignant neoplasms of ill-defined, secondary and unspecified sites	0.057	0.943	0.000
C79 Secondary malignant neoplasm of other sites	0.050	0.950	0.000
C79.0 Secondary malignant neoplasm of kidney and renal pelvis	0.044	0.956	0.000
C79.7 Secondary malignant neoplasm of adrenal gland	0.043	0.957	0.000
C76 Malignant neoplasm of other and ill-defined sites	0.041	0.959	0.000
C80 Malignant neoplasm without specification of site	0.039	0.961	0.000
C79.6 Secondary malignant neoplasm of ovary	0.037	0.963	0.000
C79.2 Secondary malignant neoplasm of skin	0.036	0.963	0.000
C79.4 Secondary malignant neoplasm of other and unspecified parts of nervous system	0.036	0.964	0.000
C79.1 Secondary malignant neoplasm of bladder and other and unspecified urinary organs	0.036	0.964	0.000
C79.9 Secondary malignant neoplasm, unspecified site	0.035	0.965	0.000
C79.5 Secondary malignant neoplasm of bone and bone marrow	0.034	0.966	0.000
C79.8 Secondary malignant neoplasm of other specified sites	0.033	0.967	0.000
C77 Secondary and unspecified malignant neoplasm of lymph nodes	0.033	0.967	0.000
C79.3 Secondary malignant neoplasm of brain and cerebral meninges	0.030	0.970	0.000
C76.8 Overlapping lesion of other and ill-defined sites	0.029	0.970	0.000
C76.7 Other ill-defined sites	0.029	0.970	0.000
C76.5 Lower limb	0.029	0.970	0.000
C76.4 Upper limb	0.029	0.970	0.000
C76.3 Pelvis	0.029	0.970	0.000
C76.2 Abdomen	0.029	0.970	0.000
C76.1 Thorax	0.029	0.970	0.000
C76.0 Head, face and neck	0.029	0.970	0.000
C80.9 Malignant neoplasm, unspecified	0.028	0.972	0.000
I50.1 Left ventricular failure	0.000	0.973	0.027
C77.0 Lymph nodes of head, face and neck	0.027	0.973	0.000
C80.0 Malignant neoplasm, primary site unknown, so stated	0.026	0.974	0.000
C77.4 Inguinal and lower limb lymph nodes	0.025	0.975	0.000
C77.8 Lymph nodes of multiple regions	0.025	0.975	0.000
C77.1 Intrathoracic lymph nodes	0.024	0.976	0.000
B95.6 Staphylococcus aureus as the cause of diseases classified to other chapters	0.000	0.978	0.022
C77.5 Intrapelvic lymph nodes	0.022	0.978	0.000
C77.2 Intra-abdominal lymph nodes	0.021	0.979	0.000
B95 Streptococcus and staphylococcus as the cause of diseases classified to other chapters	0.000	0.982	0.018
C77.9 Lymph node, unspecified	0.017	0.983	0.000
C77.3 Axillary and upper limb lymph nodes	0.017	0.983	0.000
B96 Other bacterial agents as the cause of diseases classified to other chapters	0.000	0.983	0.017
B95-B98 Bacterial, viral and other infectious agents	0.000	0.983	0.017
B98 Other specified infectious agents as the cause of diseases classified to other chapters	0.000	0.985	0.015
B95.8 Unspecified staphylococcus as the cause of diseases classified to other chapters	0.000	0.985	0.015
B96.5 Pseudomonas (aeruginosa)(mallei)(pseudomallei) as the cause of diseases classified to other chapters	0.000	0.985	0.015
B96.4 Proteus (mirabilis)(morganii) as the cause of diseases classified to other chapters	0.000	0.986	0.014
B98.0 Helicobacter pylori [H.pylori] as the cause of diseases classified to other chapters	0.000	0.986	0.014
B96.2 Escherichia coli [E. coli] as the cause of diseases classified to other chapters	0.000	0.986	0.014
B95.7 Other staphylococcus as the cause of diseases classified to other chapters	0.000	0.986	0.013
B95.3 Streptococcus pneumoniae as the cause of diseases classified to other chapters	0.000	0.987	0.013
B95.2 Streptococcus, group D, as the cause of diseases classified to other chapters	0.000	0.987	0.013
B95.0 Streptococcus, group A, as the cause of diseases classified to other chapters	0.000	0.987	0.013
B95.4 Other streptococcus as the cause of diseases classified to other chapters	0.000	0.987	0.013
B96.8 Other specified bacterial agents as the cause of diseases classified to other chapters	0.000	0.987	0.013
B96.3 Haemophilus influenzae [H. influenzae] as the cause of diseases classified to other chapters	0.000	0.987	0.013
B96.1 Klebsiella pneumoniae [K. pneumoniae] as the cause of diseases classified to other chapters	0.000	0.987	0.013
B95.1 Streptococcus, group B, as the cause of diseases classified to other chapters	0.000	0.987	0.012
B96.7 Clostridium perfringens [C. perfringens] as the cause of diseases classified to other chapters	0.000	0.988	0.012
B96.6 Bacillus fragilis [B. fragilis] as the cause of diseases classified to other chapters	0.000	0.988	0.012
B96.0 Mycoplasma pneumoniae [M. pneumoniae] as the cause of diseases classified to other chapters	0.000	0.988	0.012
B97 Viral agents as the cause of diseases classified to other chapters	0.000	0.989	0.011
B98.1 Vibrio vulnificus as the cause of diseases classified to other chapters	0.000	0.989	0.011
B95.5 Unspecified streptococcus as the cause of diseases classified to other chapters	0.000	0.991	0.009
I50 Heart failure	0.000	0.991	0.009
B97.8 Other viral agents as the cause of diseases classified to other chapters	0.000	0.992	0.008
B97.6 Parvovirus as the cause of diseases classified to other chapters	0.000	0.992	0.008
B97.5 Reovirus as the cause of diseases classified to other chapters	0.000	0.992	0.008
B97.4 Respiratory synctial virus as the cause of diseases classified to other chapters	0.000	0.992	0.008
B97.3 Retrovirus as the cause of diseases classified to other chapters	0.000	0.992	0.008
B97.2 Coronavirus as the cause of diseases classified to other chapters	0.000	0.992	0.008
B97.1 Enterovirus as the cause of diseases classified to other chapters	0.000	0.992	0.008
B97.0 Adenovirus as the cause of diseases classified to other chapters	0.000	0.992	0.008
B97.7 Papillomavirus as the cause of diseases classified to other chapters	0.000	0.992	0.007
I50.9 Heart failure, unspecified	0.000	0.994	0.006
I50.0 Congestive heart failure	0.000	0.994	0.005
C18.2 Ascending colon	0.005	0.995	0.000
C18 Malignant neoplasm of colon	0.005	0.995	0.000
C15-C26 Malignant neoplasms of digestive organs	0.005	0.995	0.000
C16 Malignant neoplasm of stomach	0.005	0.995	0.000
C25.0 Head of pancreas	0.005	0.995	0.000
Y43.3 Other antineoplastic drugs	0.005	0.995	0.000
C18.0 Caecum	0.005	0.995	0.000
C16.5 Lesser curvature of stomach, unspecified	0.005	0.995	0.000
C25 Malignant neoplasm of pancreas	0.005	0.995	0.000
C16.9 Stomach, unspecified	0.004	0.995	0.000
K57.3 Diverticular disease of large intestine without perforation or abscess	0.004	0.996	0.000
Y43 Primarily systemic agents	0.004	0.996	0.000
Chapter II Neoplasms	0.004	0.996	0.000
C22 Malignant neoplasm of liver and intrahepatic bile ducts	0.004	0.996	0.000
C21 Malignant neoplasm of anus and anal canal	0.004	0.996	0.000
C18.4 Transverse colon	0.004	0.996	0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.004	0.996	0.000
C18.3 Hepatic flexure	0.004	0.996	0.000
C26 Malignant neoplasm of other and ill-defined digestive organs	0.004	0.996	0.000
C18.8 Overlapping lesion of colon	0.004	0.996	0.000
C18.5 Splenic flexure	0.004	0.996	0.000
C18.1 Appendix	0.004	0.996	0.000
C24 Malignant neoplasm of other and unspecified parts of biliary tract	0.004	0.996	0.000
C17 Malignant neoplasm of small intestine	0.004	0.996	0.000
C23 Malignant neoplasm of gallbladder	0.004	0.996	0.000
C18.9 Colon, unspecified	0.004	0.996	0.000
Y44.2 Anticoagulants	0.004	0.996	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.004	0.996	0.000
R55 Syncope and collapse	0.000	0.996	0.004
C73-C75 Malignant neoplasms of thyroid and other endocrine glands	0.004	0.996	0.000
C16.8 Overlapping lesion of stomach	0.004	0.996	0.000
C16.6 Greater curvature of stomach, unspecified	0.004	0.996	0.000
C16.4 Pylorus	0.004	0.996	0.000
C16.3 Pyloric antrum	0.004	0.996	0.000
C16.2 Body of stomach	0.004	0.996	0.000
C16.1 Fundus of stomach	0.004	0.996	0.000
Y44 Agents primarily affecting blood constituents	0.004	0.996	0.000
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx	0.004	0.996	0.000
Y42.7 Androgens and anabolic congeners	0.004	0.996	0.000
Y43.4 Immunosuppressive agents	0.004	0.996	0.000
C25.8 Overlapping lesion of pancreas	0.003	0.996	0.000
C25.7 Other parts of pancreas	0.003	0.996	0.000
C25.4 Endocrine pancreas	0.003	0.996	0.000
C25.3 Pancreatic duct	0.003	0.996	0.000
C25.2 Tail of pancreas	0.003	0.996	0.000
C25.1 Body of pancreas	0.003	0.996	0.000
Y52 Agents primarily affecting the cardiovascular system	0.003	0.996	0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes	0.003	0.997	0.000
C15 Malignant neoplasm of oesophagus	0.003	0.997	0.000
Y42.5 Other oestrogens and progestogens	0.003	0.997	0.000
C73 Malignant neoplasm of thyroid gland	0.003	0.997	0.000
C21.0 Anus, unspecified	0.003	0.997	0.000
Y43.9 Primarily systemic agent, unspecified	0.003	0.997	0.000
Y43.8 Other primarily systemic agents, not elsewhere classified	0.003	0.997	0.000
Y43.6 Enzymes, not elsewhere classified	0.003	0.997	0.000
Y43.5 Acidifying and alkalising agents	0.003	0.997	0.000
Y43.2 Antineoplastic natural products	0.003	0.997	0.000
Y43.1 Antineoplastic antimetabolites	0.003	0.997	0.000
Y43.0 Antiallergic and antiemetic drugs	0.003	0.997	0.000
C18.6 Descending colon	0.003	0.997	0.000
C22.0 Liver cell carcinoma	0.003	0.997	0.000
C22.9 Liver, unspecified	0.003	0.997	0.000
C20 Malignant neoplasm of rectum	0.003	0.997	0.000
C97-C97 Malignant neoplasms of independent (primary) multiple sites	0.003	0.997	0.000
C40-C41 Malignant neoplasms of bone and articular cartilage	0.003	0.997	0.000
C22.1 Intrahepatic bile duct carcinoma	0.003	0.997	0.000
D37-D48 Neoplasms of uncertain or unknown behaviour	0.003	0.997	0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.003	0.997	0.000
C22.7 Other specified carcinomas of liver	0.003	0.997	0.000
C22.4 Other sarcomas of liver	0.003	0.997	0.000
C22.3 Angiosarcoma of liver	0.003	0.997	0.000
C22.2 Hepatoblastoma	0.003	0.997	0.000
C21.8 Overlapping lesion of rectum, anus and anal canal	0.003	0.997	0.000
C21.2 Cloacogenic zone	0.003	0.997	0.000
C21.1 Anal canal	0.003	0.997	0.000
Y41 Other systemic anti-infectives and antiparasitics	0.003	0.997	0.000
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system	0.003	0.997	0.000
C45-C49 Malignant neoplasms of mesothelial and soft tissue	0.003	0.997	0.000
C26.0 Intestinal tract, part unspecified	0.003	0.997	0.000
C01 Malignant neoplasm of base of tongue	0.003	0.997	0.000
Y52.4 Angiotensin-converting-enzyme inhibitors	0.003	0.997	0.000
Y57 Other and unspecified drugs and medicaments	0.003	0.997	0.000
Y42.9 Other and unspecified hormone antagonists	0.003	0.997	0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.003	0.997	0.000
Y42.4 Oral contraceptives	0.003	0.997	0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.003	0.997	0.000
Y42.2 Antithyroid drugs	0.003	0.997	0.000
Y42.1 Thyroid hormones and substitutes	0.003	0.997	0.000
Y42.0 Glucocorticoids and synthetic analogs	0.003	0.997	0.000
C26.9 Ill-defined sites within the digestive system	0.003	0.997	0.000
C26.8 Overlapping lesion of digestive system	0.003	0.997	0.000
C26.1 Spleen	0.003	0.997	0.000
C09 Malignant neoplasm of tonsil	0.003	0.997	0.000
C25.9 Pancreas, unspecified	0.003	0.997	0.000
C02 Malignant neoplasm of other and unspecified parts of tongue	0.003	0.997	0.000
C17.9 Small intestine, unspecified	0.003	0.997	0.000
C17.8 Overlapping lesion of small intestine	0.003	0.997	0.000
C17.3 Meckel's diverticulum	0.003	0.997	0.000
C17.2 Ileum	0.003	0.997	0.000
C17.1 Jejunum	0.003	0.997	0.000
C17.0 Duodenum	0.003	0.997	0.000
C24.9 Biliary tract, unspecified	0.003	0.997	0.000
C24.8 Overlapping lesion of biliary tract	0.003	0.997	0.000
C24.1 Ampulla of Vater	0.003	0.997	0.000
C24.0 Extrahepatic bile duct	0.003	0.997	0.000
D43 Neoplasm of uncertain or unknown behaviour of brain and central nervous system	0.003	0.997	0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.003	0.997	0.000
Y59 Other and unspecified vaccines and biological substances	0.003	0.997	0.000
Y58 Bacterial vaccines	0.003	0.997	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.003	0.997	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.003	0.997	0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.003	0.997	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.003	0.997	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.003	0.997	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.003	0.997	0.000
Y48 Anaesthetics and therapeutic gases	0.003	0.997	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.003	0.997	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.003	0.997	0.000
K57.9 Diverticular disease of intestine, part unspecified, without perforation or abscess	0.003	0.997	0.000
C75 Malignant neoplasm of other endocrine glands and related structures	0.003	0.997	0.000
C74 Malignant neoplasm of adrenal gland	0.003	0.997	0.000
Y44.9 Other and unspecified agents affecting blood constituents	0.003	0.997	0.000
Y44.7 Plasma substitutes	0.003	0.997	0.000
Y44.6 Natural blood and blood products	0.003	0.997	0.000
Y44.5 Thrombolytic drugs	0.003	0.997	0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.003	0.997	0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.003	0.997	0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.003	0.997	0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.003	0.997	0.000
C14 Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx	0.003	0.997	0.000
C13 Malignant neoplasm of hypopharynx	0.003	0.997	0.000
C11 Malignant neoplasm of nasopharynx	0.003	0.997	0.000
C10 Malignant neoplasm of oropharynx	0.003	0.997	0.000
C08 Malignant neoplasm of other and unspecified major salivary glands	0.003	0.997	0.000
C06 Malignant neoplasm of other and unspecified parts of mouth	0.003	0.997	0.000
C05 Malignant neoplasm of palate	0.003	0.997	0.000
C04 Malignant neoplasm of floor of mouth	0.003	0.997	0.000
C03 Malignant neoplasm of gum	0.003	0.997	0.000
C00 Malignant neoplasm of lip	0.003	0.997	0.000
C12 Malignant neoplasm of pyriform sinus	0.003	0.997	0.000
C07 Malignant neoplasm of parotid gland	0.003	0.997	0.000
Y40 Systemic antibiotics	0.003	0.997	0.000
D43.2 Brain, unspecified	0.003	0.997	0.000
K01.1 Impacted teeth	0.003	0.997	0.000
C16.0 Cardia	0.003	0.997	0.000
D48 Neoplasm of uncertain or unknown behaviour of other and unspecified sites	0.003	0.997	0.000
D00-D09 In situ neoplasms	0.003	0.997	0.000
C92 Myeloid leukaemia	0.003	0.997	0.000
D47 Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue	0.003	0.997	0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.003	0.997	0.000
Y52.8 Antivaricose drugs, including sclerosing agents	0.003	0.997	0.000
Y52.7 Peripheral vasodilators	0.003	0.997	0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.003	0.997	0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.003	0.997	0.000
Y52.3 Coronary vasodilators, not elsewhere classified	0.003	0.997	0.000
Y52.1 Calcium-channel blockers	0.003	0.997	0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.003	0.997	0.000
C15.8 Overlapping lesion of oesophagus	0.003	0.997	0.000
C15.4 Middle third of oesophagus	0.003	0.997	0.000
C15.3 Upper third of oesophagus	0.003	0.997	0.000
C15.2 Abdominal part of oesophagus	0.003	0.997	0.000
C15.1 Thoracic part of oesophagus	0.003	0.997	0.000
C15.0 Cervical part of oesophagus	0.003	0.997	0.000
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.003	0.997	0.000
C30-C39 Malignant neoplasms of respiratory and intrathoracic organs	0.003	0.997	0.000
K57 Diverticular disease of intestine	0.003	0.997	0.000
C18.7 Sigmoid colon	0.003	0.997	0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.003	0.997	0.000
D38 Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs	0.003	0.997	0.000
C91 Lymphoid leukaemia	0.003	0.997	0.000
Y57.9 Drug or medicament, unspecified	0.003	0.997	0.000
C81 Hodgkin's disease	0.003	0.997	0.000
C42 hematopoietic and reticuloendothelial systems (ICD-O-3 specific)	0.002	0.997	0.000
C41 Malignant neoplasm of bone and articular cartilage of other and unspecified sites	0.002	0.997	0.000
C40 Malignant neoplasm of bone and articular cartilage of limbs	0.002	0.997	0.000
C97 Malignant neoplasms of independent (primary) multiple sites	0.002	0.997	0.000
C19 Malignant neoplasm of rectosigmoid junction	0.002	0.997	0.000
C09.9 Tonsil, unspecified	0.002	0.997	0.000
K29.5 Chronic gastritis, unspecified	0.000	0.997	0.003
D47.3 Essential (haemorrhagic) thrombocythaemia	0.002	0.997	0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.002	0.997	0.000
C95 Leukaemia of unspecified cell type	0.002	0.997	0.000
C94 Other leukaemias of specified cell type	0.002	0.997	0.000
C93 Monocytic leukaemia	0.002	0.997	0.000
C88 Malignant immunoproliferative diseases	0.002	0.997	0.000
C86 Other specified types of T/NK-cell lymphoma	0.002	0.997	0.000
C84 Peripheral and cutaneous T-cell lymphomas	0.002	0.997	0.000
D44 Neoplasm of uncertain or unknown behaviour of endocrine glands	0.002	0.997	0.000
D42 Neoplasm of uncertain or unknown behaviour of meninges	0.002	0.997	0.000
D40 Neoplasm of uncertain or unknown behaviour of male genital organs	0.002	0.997	0.000
R13 Dysphagia	0.003	0.997	0.000
C92.0 Acute myeloid leukaemia	0.002	0.997	0.000
D46 Myelodysplastic syndromes	0.002	0.997	0.000
C02.9 Tongue, unspecified	0.002	0.997	0.000
C15.9 Oesophagus, unspecified	0.002	0.997	0.000
H91.9 Hearing loss, unspecified	0.000	0.997	0.003
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.002	0.997	0.000
Y41.5 Antiviral drugs	0.002	0.997	0.000
Y41.4 Anthelminthics	0.002	0.997	0.000
Y41.3 Other antiprotozoal drugs	0.002	0.997	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.002	0.997	0.000
Y41.1 Antimycobacterial drugs	0.002	0.997	0.000
Y41.0 Sulphonamides	0.002	0.997	0.000
C49 Malignant neoplasm of other connective and soft tissue	0.002	0.997	0.000
C48 Malignant neoplasm of retroperitoneum and peritoneum	0.002	0.997	0.000
C47 Malignant neoplasm of peripheral nerves and autonomic nervous system	0.002	0.997	0.000
C46 Kaposi's sarcoma	0.002	0.997	0.000
C72 Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system	0.002	0.997	0.000
C70 Malignant neoplasm of meninges	0.002	0.997	0.000
C69 Malignant neoplasm of eye and adnexa	0.002	0.997	0.000
Y51 Drugs primarily affecting the autonomic nervous system	0.002	0.997	0.000
C15.5 Lower third of oesophagus	0.002	0.997	0.000
D39 Neoplasm of uncertain or unknown behaviour of female genital organs	0.002	0.997	0.000
Y57.8 Other drugs and medicaments	0.002	0.997	0.000
Y57.7 Vitamins, not elsewhere classified	0.002	0.997	0.000
Y57.6 Other diagnostic agents	0.002	0.997	0.000
Y57.5 X-ray contrast media	0.002	0.997	0.000
Y57.4 Pharmaceutical excipients	0.002	0.997	0.000
Y57.3 Alcohol deterrents	0.002	0.997	0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.002	0.997	0.000
Y57.1 Lipotropic drugs	0.002	0.997	0.000
Y57.0 Appetite depressants [anorectics]	0.002	0.997	0.000
D06 Carcinoma in situ of cervix uteri	0.002	0.997	0.000
C43-C44 Melanoma and other malignant neoplasms of skin	0.003	0.997	0.000
D48.5 Skin	0.002	0.997	0.000
C32 Malignant neoplasm of larynx	0.002	0.997	0.000
O03.4 Incomplete, without complication	0.002	0.997	0.000
Y40.8 Other systemic antibiotics	0.002	0.997	0.000
C02.8 Overlapping lesion of tongue	0.002	0.998	0.000
C02.4 Lingual tonsil	0.002	0.998	0.000
C02.3 Anterior two-thirds of tongue, part unspecified	0.002	0.998	0.000
C02.2 Ventral surface of tongue	0.002	0.998	0.000
C02.1 Border of tongue	0.002	0.998	0.000
C02.0 Dorsal surface of tongue	0.002	0.998	0.000
C09.8 Overlapping lesion of tonsil	0.002	0.998	0.000
C09.1 Tonsillar pillar (anterior) (posterior)	0.002	0.998	0.000
C09.0 Tonsillar fossa	0.002	0.998	0.000
C71 Malignant neoplasm of brain	0.002	0.998	0.000
D43.9 Central nervous system, unspecified	0.002	0.998	0.000
D43.7 Other parts of central nervous system	0.002	0.998	0.000
D43.4 Spinal cord	0.002	0.998	0.000
D43.3 Cranial nerves	0.002	0.998	0.000
D43.1 Brain, infratentorial	0.002	0.998	0.000
D43.0 Brain, supratentorial	0.002	0.998	0.000
D47.1 Chronic myeloproliferative disease	0.002	0.998	0.000
D48.6 Breast	0.002	0.998	0.000
C45 Mesothelioma	0.002	0.998	0.000
D03 Melanoma in situ	0.002	0.998	0.000
Y46.8 Antispasticity drugs	0.002	0.998	0.000
Y46.7 Anti-Parkinsonism drugs	0.002	0.998	0.000
Y46.6 Other and unspecified antiepileptics	0.002	0.998	0.000
Y46.5 Valproic acid	0.002	0.998	0.000
Y46.4 Iminostilbenes	0.002	0.998	0.000
Y46.3 Deoxybarbiturates	0.002	0.998	0.000
Y46.2 Hydantoin derivatives	0.002	0.998	0.000
Y46.1 Oxazolidinediones	0.002	0.998	0.000
Y46.0 Succinimides	0.002	0.998	0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.002	0.998	0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.002	0.998	0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.002	0.998	0.000
Y47.4 Bromine compounds	0.002	0.998	0.000
Y47.3 Paraldehyde	0.002	0.998	0.000
Y47.2 Chloral derivatives	0.002	0.998	0.000
Y47.1 Benzodiazepines	0.002	0.998	0.000
Y47.0 Barbiturates, not elsewhere classified	0.002	0.998	0.000
Y48.5 Therapeutic gases	0.002	0.998	0.000
Y48.4 Anaesthetic, unspecified	0.002	0.998	0.000
Y48.3 Local anaesthetics	0.002	0.998	0.000
Y48.2 Other and unspecified general anaesthetics	0.002	0.998	0.000
Y48.1 Parenteral anaesthetics	0.002	0.998	0.000
Y48.0 Inhaled anaesthetics	0.002	0.998	0.000
Y49.9 Psychotropic drug, unspecified	0.002	0.998	0.000
Y49.8 Other psychotropic drugs, not elsewhere classified	0.002	0.998	0.000
Y49.7 Psychostimulants with abuse potential	0.002	0.998	0.000
Y49.6 Psychodysleptics [hallucinogens]	0.002	0.998	0.000
Y49.5 Other antipsychotics and neuroleptics	0.002	0.998	0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.002	0.998	0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.002	0.998	0.000
Y49.2 Other and unspecified antidepressants	0.002	0.998	0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.002	0.998	0.000
Y49.0 Tricyclic and tetracyclic antidepressants	0.002	0.998	0.000
Y50.9 Central nervous system stimulant, unspecified	0.002	0.998	0.000
Y50.8 Other central nervous system stimulants	0.002	0.998	0.000
Y50.2 Methylxanthines, not elsewhere classified	0.002	0.998	0.000
Y50.1 Opioid receptor antagonists	0.002	0.998	0.000
Y50.0 Analeptics	0.002	0.998	0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.002	0.998	0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.002	0.998	0.000
Y53.7 Emetics	0.002	0.998	0.000
Y53.6 Antidiarrhoeal drugs	0.002	0.998	0.000
Y53.5 Digestants	0.002	0.998	0.000
Y53.4 Other laxatives	0.002	0.998	0.000
Y53.3 Saline and osmotic laxatives	0.002	0.998	0.000
Y53.2 Stimulant laxatives	0.002	0.998	0.000
Y53.1 Other antacids and anti-gastric-secretion drugs	0.002	0.998	0.000
Y53.0 Histamine H2-receptor antagonists	0.002	0.998	0.000
Y54.9 Mineral salts, not elsewhere classified	0.002	0.998	0.000
Y54.8 Agents affecting uric acid metabolism	0.002	0.998	0.000
Y54.7 Agents affecting calcification	0.002	0.998	0.000
Y54.6 Electrolytic, caloric and water-balance agents	0.002	0.998	0.000
Y54.5 Other diuretics	0.002	0.998	0.000
Y54.4 Loop [high-ceiling] diuretics	0.002	0.998	0.000
Y54.3 Benzothiadiazine derivatives	0.002	0.998	0.000
Y54.2 Carbonic-anhydrase inhibitors	0.002	0.998	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.002	0.998	0.000
Y54.0 Mineralocorticoids	0.002	0.998	0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.002	0.998	0.000
Y55.6 Antiasthmatics, not elsewhere classified	0.002	0.998	0.000
Y55.5 Anticommon cold drugs	0.002	0.998	0.000
Y55.4 Expectorants	0.002	0.998	0.000
Y55.3 Antitussives	0.002	0.998	0.000
Y55.2 Other and unspecified agents primarily acting on muscles	0.002	0.998	0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.002	0.998	0.000
Y55.0 Oxytocic drugs	0.002	0.998	0.000
Y56.9 Topical agent, unspecified	0.002	0.998	0.000
Y56.8 Other topical agents	0.002	0.998	0.000
Y56.7 Dental drugs, topically applied	0.002	0.998	0.000
Y56.6 Otorhinolaryngological drugs and preparations	0.002	0.998	0.000
Y56.5 Ophthalmological drugs and preparations	0.002	0.998	0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.002	0.998	0.000
Y56.3 Emollients, demulcents and protectants	0.002	0.998	0.000
Y56.2 Local astringents and local detergents	0.002	0.998	0.000
Y56.1 Antipruritics	0.002	0.998	0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.002	0.998	0.000
Y58.9 Other and unspecified bacterial vaccines	0.002	0.998	0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.002	0.998	0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.002	0.998	0.000
Y58.5 Diphtheria vaccine	0.002	0.998	0.000
Y58.4 Tetanus vaccine	0.002	0.998	0.000
Y58.3 Plague vaccine	0.002	0.998	0.000
Y58.2 Cholera vaccine	0.002	0.998	0.000
Y58.1 Typhoid and paratyphoid vaccine	0.002	0.998	0.000
Y58.0 BCG vaccine	0.002	0.998	0.000
Y59.9 Vaccine or biological substance, unspecified	0.002	0.998	0.000
Y59.8 Other specified vaccines and biological substances	0.002	0.998	0.000
Y59.3 Immunoglobulin	0.002	0.998	0.000
Y59.2 Protozoal vaccines	0.002	0.998	0.000
Y59.1 Rickettsial vaccines	0.002	0.998	0.000
Y59.0 Viral vaccines	0.002	0.998	0.000
C83 Diffuse non-Hodgkin's lymphoma	0.002	0.998	0.000
C64-C68 Malignant neoplasms of urinary tract	0.002	0.998	0.000
C74.9 Adrenal gland, unspecified	0.002	0.998	0.000
C74.1 Medulla of adrenal gland	0.002	0.998	0.000
C74.0 Cortex of adrenal gland	0.002	0.998	0.000
C75.9 Endocrine gland, unspecified	0.002	0.998	0.000
C75.8 Pluriglandular involvement, unspecified	0.002	0.998	0.000
C75.5 Aortic body and other paraganglia	0.002	0.998	0.000
C75.4 Carotid body	0.002	0.998	0.000
C75.3 Pineal gland	0.002	0.998	0.000
C75.2 Craniopharyngeal duct	0.002	0.998	0.000
C75.1 Pituitary gland	0.002	0.998	0.000
C75.0 Parathyroid gland	0.002	0.998	0.000
D48.1 Connective and other soft tissue	0.002	0.998	0.000
Y40.9 Systemic antibiotic, unspecified	0.002	0.998	0.000
Y40.7 Antifungal antibiotics, systemically used	0.002	0.998	0.000
Y40.6 Rifamycins	0.002	0.998	0.000
Y40.5 Aminoglycosides	0.002	0.998	0.000
Y40.4 Tetracyclines	0.002	0.998	0.000
Y40.3 Macrolides	0.002	0.998	0.000
Y40.2 Chloramphenicol group	0.002	0.998	0.000
Y40.1 Cefalosporins and other -lactam antibiotics	0.002	0.998	0.000
D04 Carcinoma in situ of skin	0.002	0.998	0.000
C00.9 Lip, unspecified	0.002	0.998	0.000
C00.8 Overlapping lesion of lip	0.002	0.998	0.000
C00.6 Commissure of lip	0.002	0.998	0.000
C00.5 Lip, unspecified, inner aspect	0.002	0.998	0.000
C00.4 Lower lip, inner aspect	0.002	0.998	0.000
C00.3 Upper lip, inner aspect	0.002	0.998	0.000
C00.2 External lip, unspecified	0.002	0.998	0.000
C00.1 External lower lip	0.002	0.998	0.000
C00.0 External upper lip	0.002	0.998	0.000
C03.9 Gum, unspecified	0.002	0.998	0.000
C03.1 Lower gum	0.002	0.998	0.000
C03.0 Upper gum	0.002	0.998	0.000
C04.9 Floor of mouth, unspecified	0.002	0.998	0.000
C04.8 Overlapping lesion of floor of mouth	0.002	0.998	0.000
C04.1 Lateral floor of mouth	0.002	0.998	0.000
C04.0 Anterior floor of mouth	0.002	0.998	0.000
C05.9 Palate, unspecified	0.002	0.998	0.000
C05.8 Overlapping lesion of palate	0.002	0.998	0.000
C05.2 Uvula	0.002	0.998	0.000
C05.1 Soft palate	0.002	0.998	0.000
C05.0 Hard palate	0.002	0.998	0.000
C06.9 Mouth, unspecified	0.002	0.998	0.000
C06.8 Overlapping lesion of other and unspecified parts of mouth	0.002	0.998	0.000
C06.2 Retromolar area	0.002	0.998	0.000
C06.1 Vestibule of mouth	0.002	0.998	0.000
C06.0 Cheek mucosa	0.002	0.998	0.000
C08.9 Major salivary gland, unspecified	0.002	0.998	0.000
C08.8 Overlapping lesion of major salivary glands	0.002	0.998	0.000
C08.1 Sublingual gland	0.002	0.998	0.000
C08.0 Submandibular gland	0.002	0.998	0.000
C10.9 Oropharynx, unspecified	0.002	0.998	0.000
C10.8 Overlapping lesion of oropharynx	0.002	0.998	0.000
C10.4 Branchial cleft	0.002	0.998	0.000
C10.3 Posterior wall of oropharynx	0.002	0.998	0.000
C10.2 Lateral wall of oropharynx	0.002	0.998	0.000
C10.1 Anterior surface of epiglottis	0.002	0.998	0.000
C10.0 Vallecula	0.002	0.998	0.000
C11.9 Nasopharynx, unspecified	0.002	0.998	0.000
C11.8 Overlapping lesion of nasopharynx	0.002	0.998	0.000
C11.3 Anterior wall of nasopharynx	0.002	0.998	0.000
C11.2 Lateral wall of nasopharynx	0.002	0.998	0.000
C11.1 Posterior wall of nasopharynx	0.002	0.998	0.000
C11.0 Superior wall of nasopharynx	0.002	0.998	0.000
C13.9 Hypopharynx, unspecified	0.002	0.998	0.000
C13.8 Overlapping lesion of hypopharynx	0.002	0.998	0.000
C13.2 Posterior wall of hypopharynx	0.002	0.998	0.000
C13.1 Aryepiglottic fold, hypopharyngeal aspect	0.002	0.998	0.000
C13.0 Postcricoid region	0.002	0.998	0.000
C14.8 Overlapping lesion of lip, oral cavity and pharynx	0.002	0.998	0.000
C14.2 Waldeyer's ring	0.002	0.998	0.000
C14.0 Pharynx, unspecified	0.002	0.998	0.000
C92.1 Chronic myeloid leukaemia	0.002	0.998	0.000
D38.1 Trachea, bronchus and lung	0.002	0.998	0.000
D48.9 Neoplasms of uncertain or unknown behaviour, unspecified	0.002	0.998	0.000
D48.7 Other specified sites	0.002	0.998	0.000
D48.4 Peritoneum	0.002	0.998	0.000
D48.3 Retroperitoneum	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations